Pacific Global Investment Management Co. Sells 5,344 Shares of CVS Health Co. (NYSE:CVS)

Pacific Global Investment Management Co. trimmed its holdings in CVS Health Co. (NYSE:CVS - Free Report) by 30.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,993 shares of the pharmacy operator's stock after selling 5,344 shares during the period. Pacific Global Investment Management Co.'s holdings in CVS Health were worth $538,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently made changes to their positions in CVS. MidAtlantic Capital Management Inc. purchased a new position in CVS Health during the third quarter valued at approximately $25,000. Legacy Investment Solutions LLC purchased a new position in shares of CVS Health during the 3rd quarter valued at $31,000. Ridgewood Investments LLC increased its holdings in shares of CVS Health by 255.7% in the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock worth $28,000 after purchasing an additional 450 shares during the period. Stonebridge Financial Group LLC bought a new stake in CVS Health during the fourth quarter valued at $28,000. Finally, RPg Family Wealth Advisory LLC purchased a new position in CVS Health during the third quarter worth about $40,000. Hedge funds and other institutional investors own 80.66% of the company's stock.

Insider Buying and Selling at CVS Health

In other news, Director Michael F. Mahoney acquired 30,000 shares of the stock in a transaction on Tuesday, February 18th. The stock was acquired at an average price of $66.70 per share, with a total value of $2,001,000.00. Following the completion of the transaction, the director now owns 39,356 shares of the company's stock, valued at $2,625,045.20. This represents a 320.65 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.24% of the company's stock.

Analyst Ratings Changes

Several analysts have weighed in on CVS shares. Leerink Partnrs raised CVS Health from a "hold" rating to a "strong-buy" rating in a report on Wednesday, February 12th. UBS Group lowered their target price on shares of CVS Health from $62.00 to $59.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 11th. Edward Jones raised shares of CVS Health from a "hold" rating to a "buy" rating in a research note on Thursday, January 30th. TD Cowen raised their price objective on shares of CVS Health from $73.00 to $80.00 and gave the company a "buy" rating in a research report on Monday, November 25th. Finally, Wells Fargo & Company upped their target price on shares of CVS Health from $68.00 to $73.00 and gave the stock an "overweight" rating in a research report on Thursday, February 13th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $69.83.

CVS Health Trading Down 1.4 %

NYSE CVS traded down $0.90 on Monday, hitting $64.82. The company's stock had a trading volume of 7,077,932 shares, compared to its average volume of 12,413,927. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75. The firm has a market cap of $81.72 billion, a P/E ratio of 17.71, a PEG ratio of 0.98 and a beta of 0.61. The company's 50-day simple moving average is $54.33 and its 200 day simple moving average is $56.47.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. Research analysts predict that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were issued a $0.665 dividend. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 annualized dividend and a yield of 4.10%. CVS Health's dividend payout ratio (DPR) is presently 72.68%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.